RECIST 1.1 assessments variability: a systematic pictorial review of blinded double reads.

Antoine Iannessi^1,2, Hubert Beaumont³, Christine Ojango², Anne-Sophie Bertrand⁴, Yan Liu²

¹Cancer Center Antoine Lacassagne 33 Av. de Valombrose, 06100, Nice, France.

²Median Technologies SA 1800 Route des Crêtes, 06560, Valbonne, France.

³Median Technologies SA 1800 Route des Crêtes, 06560, Valbonne, France. hubertbeaumont@hotmail.com.

⁴Imaging Center Beaulieu-sur-mer 18 Bd Eugène Gauthier, 06310, Beaulieu-sur-Mer, France.

PubMed PMC DOI PDF

Abstract

Reader variability is intrinsic to radiologic oncology assessments, necessitating measures to enhance consistency and accuracy. RECIST 1.1 criteria play a crucial role in mitigating this variability by standardizing evaluations, aiming to establish an accepted "truth" confirmed by histology or patient survival. Clinical trials utilize Blind Independent Centralized Review (BICR) techniques to manag…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.